Research shows that common acid-reducing medicines did not cause overall gut bacteria imbalance in healthy dogs over 30 days. According to research reviewed by Gram, a randomized trial of 20 Golden Retrievers in 2026 found no clinical illness, though small shifts in specific bacteria were seen.

Proton pump inhibitors, a common class of acid-reducing drugs, are often suspected of upsetting the gut’s bacterial balance. According to research reviewed by Gram, a 30-day trial in 20 healthy Golden Retriever dogs found that omeprazole, esomeprazole, and lansoprazole did not cause overall gut imbalance or visible health problems. Researchers did see small shifts in a few gut bacteria, including lower levels of Turicibacter in two groups and a rise in Streptococcus in some omeprazole-treated dogs. Blood markers of inflammation and nutrient absorption stayed stable. The study was small, was done only in dogs, and did not test long-term use, so these results are a useful first look rather than a final answer. Anyone concerned about gut health or medication effects should talk with a veterinarian or doctor before making changes.

Key Statistics

A 2026 randomized controlled trial of 20 Golden Retriever dogs published in PLoS One found that 30 days of omeprazole, esomeprazole, or lansoprazole did not produce an overall gut bacteria imbalance compared with placebo.

In the same 2026 dog study, researchers observed lower levels of the gut bacterium Turicibacter in the omeprazole and esomeprazole groups, while no clinical signs of illness were reported in any treatment group.

The 2026 study of 20 dogs, split into four groups of five, found that blood markers for inflammation and nutrient absorption, including folate, cobalamin, iron, and calcium, remained unchanged after 30 days of treatment.

The Quick Take

  • What they studied: Researchers wanted to know whether common heartburn and stomach-acid medicines change the types of bacteria living in the gut, and whether those changes affect health.
  • Who participated: Twenty healthy adult Golden Retriever dogs were split randomly into four groups of five. Three groups received one of three acid-reducing medicines, and one group received a placebo, a fake pill with no active medicine.
  • Key finding: The medicines did not cause an overall gut imbalance or any visible illness after 30 days. Some specific bacteria did shift, such as lower Turicibacter levels in two groups, but these changes were small and not consistent across all dogs.
  • What it means for you: This study offers reassuring early evidence that short-term use of these medicines in healthy dogs is unlikely to cause major gut problems. Because the study was small and only tested dogs, it cannot tell us how these drugs affect people or long-term users, so medical advice still matters.

The Research Details

This was a randomized controlled trial, which means chance decided which dogs received which treatment. Randomization helps prevent the groups from differing in ways that could skew the results. Each dog took its assigned pill twice a day for 30 days, with doses scaled to body weight. The three medicines tested were omeprazole, esomeprazole, and lansoprazole, and the control group took a placebo.

Researchers collected stool samples at the start and end of the trial to study the gut microbiota, the community of microbes living in the digestive tract. They used a dysbiosis index, a scoring tool that summarizes how far a gut’s bacterial makeup has drifted from a healthy baseline. They also drew blood to check nutrients such as folate, cobalamin (vitamin B12), iron, and calcium, which can signal digestive or absorption problems.

Gastrin, a hormone that signals the stomach to make acid, was measured only in the lansoprazole group. This means the study cannot fully compare hormone changes across all medicines.

A randomized design with a placebo group is one of the strongest ways to test whether a drug causes a change. Comparing the drug groups against the placebo group helps separate true medication effects from everyday variation in gut bacteria. Measuring samples before and after treatment allowed each dog to serve as its own point of comparison, which adds useful detail.

The use of random assignment and a placebo group are strengths. The study was published in PLoS One, a peer-reviewed journal, which means outside experts reviewed it before publication. However, each group had only five dogs, which is a very small number. Small studies can produce results that look meaningful by chance, and they have less power to detect smaller effects. The study also used a single breed under controlled conditions, so the findings may not apply to every dog or to other species.

What the Results Show

The main result was that none of the three acid-reducing medicines changed the overall dysbiosis index compared with placebo. In plain terms, the dogs’ gut bacterial communities did not shift into an unhealthy pattern on average. No dog showed clinical signs of illness during the trial, which suggests the medicines were well tolerated over this period.

The study did find some specific changes. Turicibacter, a type of gut bacterium, decreased in the omeprazole and esomeprazole groups. Streptococcus, a bacterial genus that includes some species linked to infections in people, increased in a few dogs in the omeprazole group. Researchers describe these as isolated changes, meaning they did not appear in every dog and did not add up to a broader imbalance.

Blood tests showed that markers of inflammation and nutrient absorption, including folate, cobalamin, iron, and calcium, remained stable. This suggests that, at least over 30 days, the medicines did not appear to interfere with the body’s ability to absorb key nutrients. Researchers did not report any changes in gastrin levels in the lansoprazole group in the summary provided.

Taken together, the results point toward a mostly reassuring picture. The medicines did not produce a clear, widespread disruption of gut bacteria, but the shifts in a few bacteria show that the gut microbiome can respond to these drugs in small ways.

The reduction in Turicibacter is interesting because this bacterium has been studied in relation to gut health and immune function, although its exact role is still being explored. Its decrease in two drug groups is a specific signal worth following up in larger studies. The rise in Streptococcus in some omeprazole-treated dogs is also notable, since it shows that individual animals can respond differently to the same medicine.

The lack of change in inflammation and absorption markers adds useful context. Even where bacteria shifted, the body’s measurable indicators of digestive stress did not show a clear change, which suggests the bacterial shifts did not translate into obvious harm during this short trial.

Acid-reducing medicines are widely prescribed to dogs and people, and some earlier research has linked long-term use in people with changes in gut bacteria and nutrient absorption. This dog study fits into a growing body of work exploring those concerns. Its results suggest that short-term effects in healthy animals may be smaller than some worries imply, but they also confirm that the gut microbiome is sensitive enough to shift in specific ways. Because the study was small and short, it adds a useful piece to the picture rather than settling the question.

The most important limitation is sample size. With only five dogs per group, the study may miss real effects or overstate chance findings. Most of the specific bacterial changes were not consistent across all dogs, which makes them harder to interpret.

The study lasted only 30 days, so it cannot show what happens with months or years of use. Many people and pets take these medicines long term, and long-term effects may differ.

All participants were healthy Golden Retrievers, so the results may not apply to other breeds, to sick animals, or to humans. Gastrin levels were measured in only one group, which limits comparisons between medicines. Finally, gut microbiome analysis captures a snapshot based on stool samples, and it cannot fully explain how bacterial changes affect health.

The Bottom Line

Based on this study, there is moderate confidence that short-term use of omeprazole, esomeprazole, or lansoprazole in healthy dogs does not cause major gut imbalance or obvious illness. Confidence is lower about specific bacterial shifts, since those were small and inconsistent. Owners should not stop or start any medicine based on this study alone. Any decision about acid-reducing medication for a dog should be made with a veterinarian who knows the animal’s full health history.

Dog owners whose veterinarians have prescribed these medicines may find the results reassuring. Veterinarians and researchers studying the gut microbiome will find the bacterial shifts worth following up. People taking similar acid-reducing medicines for themselves should not apply these dog results directly, since human gut biology and dosing differ. Dogs with existing digestive disease, pregnant or nursing animals, and very young or elderly pets were not studied and need individual veterinary guidance.

In this study, changes in gut bacteria, where they occurred, were seen within the 30-day treatment period. Most dogs showed no clinical signs of trouble during that time. Whether the bacterial shifts persist, grow, or fade after stopping the medicine is unknown. Anyone interested in gut health changes should expect that meaningful, reliable answers will require longer and larger studies than this one.

Frequently Asked Questions

Do heartburn medicines like omeprazole damage a dog’s gut bacteria?

A 2026 trial of 20 healthy Golden Retrievers found that 30 days of omeprazole, esomeprazole, or lansoprazole did not cause an overall gut bacteria imbalance. Only small shifts in a few specific bacteria were seen, and no clinical illness was reported.

Are proton pump inhibitors safe for dogs over a short period?

In a 30-day randomized study of healthy dogs, proton pump inhibitors did not produce visible illness or changes in key blood nutrient markers. The study was small, so veterinarians still need to weigh risks and benefits for each individual dog.

What bacteria changed in dogs taking omeprazole or esomeprazole?

Turicibacter decreased in dogs taking omeprazole and esomeprazole in a 2026 study of 20 Golden Retrievers. Streptococcus increased in a few omeprazole-treated dogs, but these shifts were not consistent across all animals in the group.

Can I give my dog heartburn medicine without talking to a vet?

A veterinarian should guide any acid-reducing medication decision for a dog. This study tested healthy dogs for 30 days, so it does not cover sick animals, long-term use, or safe dosing for an individual pet’s health needs.

Want to Apply This Research?

  • Log each dog’s medication name, dose, and times given, then record stool quality daily using a simple 1 to 5 scale (1 is very firm, 5 is very loose or watery). Also note appetite, vomiting, and energy levels each day. Review weekly trends and share the log with your veterinarian.
  • Set a daily reminder for the medication schedule so doses are given consistently at the same times. Pair each dose with a quick check-in on stool, appetite, and behavior, and add a note if anything looks different from normal.
  • Keep a running log for the full length of any prescribed course and plan a veterinary check-in at regular intervals, such as every three to six months for long-term use. Track weight and appetite trends over time, and flag any new digestive symptoms, since these can signal the need for a professional review of the medication plan.

This article summarizes a small study of healthy dogs and is for general information only. It is not veterinary advice. Do not start, stop, or change any medication for your pet without consulting a licensed veterinarian, especially if your dog has digestive, kidney, or other health conditions. Results from dogs may not apply to humans, and anyone taking these medicines should talk with their doctor or pharmacist.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Effects of proton pump inhibitors on serum and fecal biomarkers and intestinal microbiota in dogs. , PloS one (2026). PubMed 43063192 | DOI
Topics
proton pump inhibitors omeprazole dogs gut microbiome dog digestive health dysbiosis Turicibacter acid reflux medicine canine gut bacteria